Standout Papers
Immediate Impact
3 from Science/Nature 64 standout
Citing Papers
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Works of Daniela Schulz–Ertner being referenced
Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)—Eudract number 2005–003911–63; NCT00311857
2008
Efficacy of Fractionated Stereotactic Reirradiation in Recurrent Gliomas: Long-Term Results in 172 Patients Treated in a Single Institution
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniela Schulz–Ertner | 3581 | 1628 | 1326 | 1695 | 108 | 5.8k | |
| Eugen B. Hug | 3896 | 821 | 945 | 1715 | 138 | 6.2k | |
| M. Wannenmacher | 2390 | 1253 | 1364 | 1448 | 207 | 5.9k | |
| Jean‐Jacques Mazeron | 2427 | 1141 | 793 | 1110 | 146 | 4.4k | |
| Lynn Verhey | 3973 | 910 | 667 | 3625 | 171 | 7.7k | |
| Beate Timmermann | 2278 | 1255 | 426 | 1101 | 225 | 3.9k | |
| Helen A. Shih | 3580 | 1964 | 1191 | 1540 | 235 | 6.3k | |
| Jerry D. Slater | 3806 | 477 | 538 | 2457 | 104 | 5.1k | |
| Klaus Herfarth | 3619 | 970 | 579 | 2723 | 271 | 6.7k | |
| Peter E. Huber | 3021 | 1207 | 1270 | 1030 | 256 | 11.2k | |
| Shiao Y. Woo | 3175 | 2394 | 1340 | 1844 | 169 | 7.1k |
All Works
Loading papers...